KAERUS BIOSCIENCE LIMITED

Active

Registry details

Reference data exactly as held at Companies House.

Copy registry details
Registered office
2nd Floor 168 Shoreditch High Street, London E1 6RA
Accounts type
Total Exemption Full

Company activity

The 4 most recent documents filed at Companies House.

Pre-Score for UK companies is coming soon
  1. 16/04/2026

    Termination of appointment of Howard Mayer as a director on 2026-04-01

    View PDF (1 pages)
  2. 16/04/2026

    Appointment of Guenaelle Levoir as a director on 2026-04-01

    View PDF (2 pages)
  3. 09/12/2025

    Termination of appointment of Michele Ollier as a director on 2025-12-05

    View PDF (1 pages)
  4. 14/10/2025

    Termination of appointment of Paul Sekhri as a director on 2025-10-01

    View PDF (1 pages)

Accounts and confirmation statement

The two filings Companies House requires every year, and where each one stands against its deadline today.

Annual accounts

Total Exemption Full accounts

Due in 5 days

30/09/2026Filing deadline

Next accounts made up to
31/12/2025
Last accounts made up to
31/12/2024

See the full filing history

Financial performance

The latest figures KAERUS BIOSCIENCE LIMITED filed. Okredo holds filed accounts data for 2021–2024; the year-by-year record is on the financials page.

Net Assets

£1.83M2024
-11.78%vs 2023

2023: £2.08M

Total Assets

£2.15M2024
-19.65%vs 2023

2023: £2.67M

Cash in Bank

£2.06M2024
-17.25%vs 2023

2023: £2.48M

Total Liabilities

£316.97K2024
-46.99%vs 2023

2023: £597.90K

Employees

62024
+1vs 2023

2023: 5

Of the 4 measures with an earlier filing to compare against, 4 fell. Total assets moved furthest, down 19.65% on 2023. See the full financial analysis for KAERUS BIOSCIENCE LIMITED.

Employees

Headcount as reported to Companies House for 2021–2024.

42021
52022
52023
62024
YearEmployeesChange
20246+1
202350
20225+1
20214–

Reported employee count increased from 4 in 2021 to 6 in 2024. See how headcount moved alongside the reported financials.

Credit report

It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.

Officers

11

Directors, secretaries and other appointed officers, with the period each has served.

PersonRolePeriodConnected companies
Director17/08/2022–02/05/20240
Corporate Secretary12/07/2016–03/12/201749
Director25/06/2021–Present32
Director22/05/2019–14/07/20212
Director12/07/2016–05/12/20254
Director09/02/2021–06/10/20232
Director29/06/2021–26/04/20230
Director21/04/2017–19/07/20210
Director12/03/2019–Present0
Director06/10/2023–01/10/20250
Director02/05/2024–01/04/20260

Persons with significant control

1

Individuals or entities with significant control over the company, as declared to Companies House.

PersonPeriodConnected companies
19/10/2018–Present0

Filing history and recent activity

Every document on the Companies House record, newest first.

Filings on record
42
Since 12/12/2017
Last 12 months
9
+5 vs the year before
Most recent filing
16/04/2026
5 months ago

What changed in the last year

  • Officer changes (5)Latest 16/04/2026
  • Share capitalLatest 02/10/2025
  • Accounts filedLatest 29/09/2025

Filing timeline

  1. 16/04/2026

    Termination of appointment of Howard Mayer as a director on 2026-04-01

    View PDF (1 pages)
  2. 16/04/2026

    Appointment of Guenaelle Levoir as a director on 2026-04-01

    View PDF (2 pages)
  3. 09/12/2025

    Termination of appointment of Michele Ollier as a director on 2025-12-05

    View PDF (1 pages)
  4. 14/10/2025

    Termination of appointment of Paul Sekhri as a director on 2025-10-01

    View PDF (1 pages)
  5. 02/10/2025

    Statement of capital on 2025-10-02

    View PDF (9 pages)
  6. 02/10/2025

    Statement by Directors

    View PDF (1 pages)
  7. 02/10/2025

    Resolutions

    View PDF (2 pages)
  8. 02/10/2025

    Solvency Statement dated 30/09/25

    View PDF (1 pages)
  9. 29/09/2025

    Total exemption full accounts made up to 2024-12-31

    View PDF (11 pages)
  10. 12/08/2025

    Director's details changed for Mr Francesco De Rubertis on 2025-07-11

    View PDF (2 pages)
  11. 11/08/2025

    Confirmation statement made on 2025-07-11 with updates

    View PDF (9 pages)
  12. 07/02/2025

    Statement of capital following an allotment of shares on 2024-10-01

    View PDF (8 pages)

Showing 12 of 42 filings

See when the next accounts and confirmation statement are due

Similar companies

84 UK companies are similar to KAERUS BIOSCIENCE LIMITED, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.

84 UK companies share this business profileThe 5 above are the closest matches. See every UK company registered under Research and experimental development on biotechnology.Browse the listing

About KAERUS BIOSCIENCE LIMITED

A short description of the company, written from its Companies House record.

KAERUS BIOSCIENCE LIMITED is a private limited company registered in the United Kingdom, based in 2nd Floor 168 Shoreditch High Street, London E1 6RA. Companies House classifies its business as Research and experimental development on biotechnology. It has been on the register for 10 years 2 months.

The register currently records it as active. Its 2024 accounts report net assets of £1.83M and 6 employees.

KAERUS BIOSCIENCE LIMITED: frequently asked questions

Answered from this company's own registry record and filed figures.

What does KAERUS BIOSCIENCE LIMITED do?

toggle

Companies House records KAERUS BIOSCIENCE LIMITED under one registered business activity: Research and experimental development on biotechnology (72.11 - SIC 2007).

Is KAERUS BIOSCIENCE LIMITED still active?

toggle

KAERUS BIOSCIENCE LIMITED is recorded as active on the Companies House register, and has been on it since 12/07/2016.

What are KAERUS BIOSCIENCE LIMITED's latest reported financials?

toggle

The most recent accounts Okredo holds cover 2024 and report net assets of £1.83M, total assets of £2.15M, cash in bank of £2.06M and total liabilities of £316.97K.

When did KAERUS BIOSCIENCE LIMITED last file with Companies House?

toggle

The most recent document on the record is dated 16/04/2026: Termination of appointment of Howard Mayer as a director on 2026-04-01, 5 months ago.

When are KAERUS BIOSCIENCE LIMITED's next filings due?

toggle

On the current registry record, accounts are due by 30/09/2026.

Who runs KAERUS BIOSCIENCE LIMITED?

toggle

Companies House lists 11 officers (2 currently in post) and 1 person with significant control.